HomeAI · summaries
Storia in 14 fonti
'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
AstraZeneca and Bristol Myers Squibb have denied any ongoing merger discussions. A senior source close to the matter stated no deal was ever planned. This comes after reports of preliminary talks between the two major drugmakers. AstraZeneca shares experienced a significant decline following the initial deal speculation. Both companies declined to comment on the reported discussions.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
- ·
benzinga.com
AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)
AstraZeneca in talks to merge with Bristol Myers Squibb, creating $400B pharma giant, while talks ongoing for months, antitrust scrutiny is expected.
